Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinical Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Very Early-Onset Inflammatory Bowel Disease Caused by IL-10RA Mutation].

Zhongguo shi yan xue ye xue za zhi - 1 Feb 2026

Wang Chao-Rong, Gao Hai-Li, Mao Yan-Na, Su Yu-Tai, Tian Liang, Ma Ping, Liu Wei, Wang Ya-Feng

Abstract excerpt

OBJECTIVE: To investigate the clinical efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in the treatment of very early-onset inflammatory bowel disease (VEO-IBD) caused by IL-10RA gene mutation. METHODS: The clinical data of 6 pediatric patients with VEO-IBD caused by IL-10RA gene mutation who underwent allo-HSCT at Henan Children's Hospital Zhengzhou Children's Hospital from October...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child, Preschool
Share to Graft vs Host Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematopoietic Stem Cell Transplantation

Share to Infant

Share to Inflammatory Bowel Diseases

Share to Mutation

Share to Transplantation, Homologous

Source

Identifiers

PMID: 41846353
DOI: 10.19746/j.cnki.issn.1009-2137.2026.01.024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinical Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Very Early-Onset Inflammatory Bowel Disease Caused by IL-10RA Mutation].PMID 41846353Read ↗

Matched Unrelated Donor Hematopoietic Stem Cell Transplant as Successful Curative Therapy for IL10RB Mutation-Associated Very Early Onset IBD.Semantic proximity Read ↗

Thalidomide-mediated immunomodulation in a patient with IL-10RA deficiency-associated very early-onset inflammatory bowel disease.Semantic proximity Read ↗

Phenotype and Management of Infantile-onset Inflammatory Bowel Disease: Experience from a Tertiary Care Center in China.Semantic proximity Read ↗

Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study.Semantic proximity Read ↗

[Clinical and genetic analysis of a very early-onset inflammatory bowel disease type 28 child with atypical clinical manifestation].Semantic proximity Read ↗

Clinical phenotypes and genotypic characteristics of infantile-onset inflammatory bowel disease with interleukin-10 receptor A mutations in 22 Chinese childrenSemantic proximity Read ↗

Unrelated umbilical cord blood transplantation using a noval conditioning regimen for small month-old infants with rare non-malignant disordersSemantic proximity Read ↗

The clinical, molecular, and therapeutic features of patients with IL10/IL10R deficiency: a systematic review.Semantic proximity Read ↗

Comprehensive mutation screening for 10 genes in Chinese patients suffering very early onset inflammatory bowel disease.Semantic proximity Read ↗

Exploring genotype-phenotype correlations in three pediatric patients with IL10RA variants and very early-onset inflammatory bowel disease.Semantic proximity Read ↗

A Comprehensive Review of IL-10 and IL-10 Receptor Deficiencies: From Basic Science to Clinical Bedside.Semantic proximity Read ↗

Very early-onset inflammatory bowel disease (IBD) in infancy is a different disease entity from adult-onset IBD; one form of interleukin-10 receptor mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.